大葉大學圖書館 |

登入

回首頁

Translational research in muscular d...

Miyagoe-Suzuki, Yuko.

Translational research in muscular dystrophy[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	616.748
書名/作者:	Translational research in muscular dystrophy/ edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura.
其他作者:	Takeda, Shin'ichi.
出版者:	Tokyo : : Springer Japan :, 2016.
面頁冊數:	viii, 199 p. : : ill., digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Muscular dystrophy - Research.
標題:	Medicine & Public Health.
標題:	Neurology.
標題:	Molecular Medicine.
標題:	Gene Therapy.
ISBN:	9784431556787
ISBN:	9784431556770
摘要、提要註:	This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies. It also describes the current systems for clinical trials and MD patient databases, resources, which will support the early realization of clinical application and improve patients' quality of life. MD is the one of the most widely known inherited neuromuscular diseases and is classified into diverse types by symptoms, age of onset, mode of inheritance, and clinical progression. With the development of molecular biology, the occurrence mechanisms of each type of MD are gradually being elucidated. Although there is no known permanent cure yet, the stage of treatment research has now advanced to clinical trials.
電子資源:	http://dx.doi.org/10.1007/978-4-431-55678-7

Translational research in muscular dystrophy[electronic resource] /
Translational research in muscular dystrophy[electronic resource] /edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura. - Tokyo :Springer Japan :2016. - viii, 199 p. :ill., digital ;24 cm.

This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies. It also describes the current systems for clinical trials and MD patient databases, resources, which will support the early realization of clinical application and improve patients' quality of life. MD is the one of the most widely known inherited neuromuscular diseases and is classified into diverse types by symptoms, age of onset, mode of inheritance, and clinical progression. With the development of molecular biology, the occurrence mechanisms of each type of MD are gradually being elucidated. Although there is no known permanent cure yet, the stage of treatment research has now advanced to clinical trials.

ISBN: 9784431556787

Standard No.: 10.1007/978-4-431-55678-7doiSubjects--Topical Terms:

656543
Muscular dystrophy
--Research.

LC Class. No.: RC935.M7

Dewey Class. No.: 616.748

Translational research in muscular dystrophy[electronic resource] /
LDR:01821nam a2200301 a 4500 001 456842
003 DE-He213
005 20160822105534.0
006 m d
007 cr nn 008maaau
008 161227s2016 ja s 0 eng d
020 $a 9784431556787 $q (electronic bk.)
020 $a 9784431556770 $q (paper)
024 7 $a 10.1007/978-4-431-55678-7 $2 doi
035 $a 978-4-431-55678-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC935.M7
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
082 0 4 $a 616.748 $2 23
090 $a RC935.M7 $b T772 2016
245 0 0 $a Translational research in muscular dystrophy $h [electronic resource] / $c edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura.
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a viii, 199 p. : $b ill., digital ; $c 24 cm.
520 $a This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies. It also describes the current systems for clinical trials and MD patient databases, resources, which will support the early realization of clinical application and improve patients' quality of life. MD is the one of the most widely known inherited neuromuscular diseases and is classified into diverse types by symptoms, age of onset, mode of inheritance, and clinical progression. With the development of molecular biology, the occurrence mechanisms of each type of MD are gradually being elucidated. Although there is no known permanent cure yet, the stage of treatment research has now advanced to clinical trials.
650 0 $a Muscular dystrophy $x Research. $3 656543
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Neurology. $3 402687
650 2 4 $a Molecular Medicine. $3 463625
650 2 4 $a Gene Therapy. $3 336987
700 1 $a Takeda, Shin'ichi. $3 656540
700 1 $a Miyagoe-Suzuki, Yuko. $3 656541
700 1 $a Mori-Yoshimura, Madoka. $3 656542
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55678-7
950 $a Medicine (Springer-11650)

筆 0 讀者評論

多媒體

多媒體檔案
http://dx.doi.org/10.1007/978-4-431-55678-7

評論

新增評論分享你的心得

Export

取書館別